AllQuantitative Report
Argus•July 14, 2021
Argus•July 14, 2021LIVN: Lowering target price to $82.00
Summary
U.K.-based LivaNova was born of a combination between Cyberonics in the
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: Abbott LaboratoriesApr 23, 2024 •
ABT
- Market Update: ABT, ERIC, IVZApr 23, 2024 •
ABT, ERIC, IVZ
- The Argus Innovation Model PortfolioApr 23, 2024 •
GOOGL, AMAT, ANET, AAPL, CVX, ADI, AXON, URI, COST, V, LLY, SPGI, PANW, META, NVDA, SYK, BSX, ORCL, CBOE, PWR, MCK, NOW, LYFT, ADBE, SCHW, MCHP, ISRG, AMZN, ODFL, CRM
- Analyst Report: Intuitive Surgical, Inc.Apr 19, 2024 •
ISRG
- Analyst Report: Abbott LaboratoriesApr 17, 2024 •
ABT